Literature DB >> 17522404

Aspirin and colon cancer--targeting prevention?

Sanford D Markowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17522404     DOI： 10.1056/NEJMe078044

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

Review 1.  Molecular targets for cancer chemoprevention.

Authors:  William N William; John V Heymach; Edward S Kim; Scott M Lippman
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

2.  Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals.

Authors:  Xuehong Zhang; Stephanie A Smith-Warner; Andrew T Chan; Kana Wu; Donna Spiegelman; Charles S Fuchs; Walter C Willett; Edward L Giovannucci
Journal:  Am J Epidemiol       Date:  2011-06-14       Impact factor: 4.897

3.  COX-2 expression in adenoma: an imperfect marker for chemoprevention.

Authors:  Andrew T Chan
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

4.  Colonic 15-PGDH levels are stable across distance and time and are not perturbed by aspirin intervention.

Authors:  Stephen P Fink; Dong-Hoon Yang; Jill S Barnholtz-Sloan; Yeon-Mi Ryu; Debra Mikkola; John D Potter; Johanna W Lampe; Sanford D Markowitz; Seung-Jae Myung
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

5.  A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in Chinese women.

Authors:  Harvey J Murff; Xiao-Ou Shu; Honglan Li; Qi Dai; Asha Kallianpur; Gong Yang; Hui Cai; Wanqing Wen; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

Review 6.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

Review 7.  The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃.

Authors:  E Vanoirbeek; A Krishnan; G Eelen; L Verlinden; R Bouillon; D Feldman; A Verstuyf
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-08       Impact factor: 4.690

Review 8.  Molecular origins of cancer: Molecular basis of colorectal cancer.

Authors:  Sanford D Markowitz; Monica M Bertagnolli
Journal:  N Engl J Med       Date:  2009-12-17       Impact factor: 91.245

9.  Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study.

Authors:  Samir Gupta; Han Sun; Sang Yi; Joy Storm; Guanghua Xiao; Bijal A Balasubramanian; Song Zhang; Raheela Ashfaq; Don C Rockey
Journal:  Cancer Prev Res (Phila)       Date:  2014-08-04

10.  15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.

Authors:  Min Yan; Seung-Jae Myung; Stephen P Fink; Earl Lawrence; James Lutterbaugh; Peiying Yang; Xiaohua Zhou; Danielle Liu; Ronald M Rerko; Joseph Willis; Dawn Dawson; Hsin-Hsiung Tai; Jill S Barnholtz-Sloan; Robert A Newman; Monica M Bertagnolli; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.